Excited to announce I've joined the WHO Fides Network! 🌍🏥 Committed to sharing reliable health info and combating misinformation. Stay tuned for evidence-based content to keep you informed and healthy. #WHOFides

🚀 GoData v50.3 is live! This release strengthens outbreak readiness and security across all supported platforms. 🦠 New WHO influenza template 🧬 Updated mpox template 🔐 Major security upgrades ⬇️ Download: https://t.co/WhaUr9kMsH 📄 Release notes: https://t.co/6WIQ6WpF0o

"We propose that the p-value be demoted from its threshold screening role and instead, treated continuously."

The ebook version of Gandhi: A Young Reader's Guide is available for preorder at introductory prices. The book will be released on Jan 26th. @nchokkan Link to US Kindle Store - https://t.co/mRD6YKAHwI Link to IN Kindle Store - https://t.co/S7NvXZRv3H

Sibling-analysis designs - a classic epidemiologic approach ⚠️ with increasing global availability of large-scale electronic health records and total-population registries. In this JAMA Guide to Statistics and Methods, the authors cover some core principles of sibling

@soniyalotlikar As per NMC rules, we r not supposed to promote brands at all @NMC_IND

I don’t think I’ve watched a better interview since 2026 began. This part: Pep speaking on Khaldoon Al Mubarak’s role, how we conduct ourselves/behave in good and bad moments, and how focusing on ourselves has always been the foundation of our success. https://t.co/5N6PrPtBim

LOL

STAY WITH ME. A few years ago, a patient was referred to me because he was diagnosed with complicated cirrhosis. He had an infection which led to a condition called hepatic encephalopathy (brain failure due to high ammonia levels). The treatment largely involved ammonia reducing

Free to read @NatureMedicine Where will GLP-1 medicines make their next impact to improve human health? https://t.co/JkCF4vJwfW

Autoregressive models are for the compute-constrained; if you are data-constrained, use diffusion models. Hybrid models - that's another thing.

Today @Gut_BMJ publishes my review titled ➡️My first 1000 manuscript rejections. I often meet young researchers who are devastated by a manuscript rejection, but rejections are part of life. Here are some of my most memorable ones 😃: https://t.co/asXsKX3CT6 @karolinskainst

Every app out there is a “AI wrapper”

“…The study exposes how international task forces have perpetuated a "pathological consensus" by recycling arbitrary surrogates rather than addressing the fundamental lack of causal validity in their designs. The author argues we must abandon the Petty-Bone RCT framework

Apparently some researchers thought it was significant that early high performance and later high performance were negatively correlated They didn't realize they were conditioning on a collider Nor did the editors at Science, who published their claims anyway Just incredible

You will live forever.. 🥹💔 #Sreenivasan

For performance, the tortoise really does beat the hare. A big new study looked at 34,000 elite performers found that: Early success rarely predicts adult achievement. Exceptional young performers peaked quickly but narrowly mastered one thing. Exceptional adults reached

“Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial” https://t.co/LaKJb4a1Jl 🙇15,596 patients with ECG 🧪 Pragmatic randomized trial 🎯 Increased detection of liver disease ✳️ Scalable, low-cost screening

"Why India Fell Off the Global Middle-Class Map" - A brilliant diagnosis of the pathologies stymying the emergence of India on global stage by @andymukherjee70 for @opinion @business Unless India, especially its 'Octopus Class' and those with aspirations/illusions of being part

“Causal inference is hard, and advanced statistical analysis is not enough” By Timothy Feeney and Paul Zivich BMJ 2025; 391 doi:

EPL Stories with Tamil meme content are vera level only…. https://t.co/Ck113bbLi9